Literature DB >> 2253230

Expression of the O6-methylguanine-DNA methyltransferase gene MGMT in MER+ and MER- human tumor cells.

A J Fornace1, M A Papathanasiou, M C Hollander, D B Yarosh.   

Abstract

DNA probes prepared from human O6-methylguanine-DNA methyltransferase complementary DNA were hybridized to mRNA isolated from human liver and fifteen human tumor cell lines proficient (Mer+) or deficient (Mer-) in transferase activity. Liver and Mer+ cells contained levels of transferase-specific mRNA that correlated with their transferase activity levels, whereas Mer- cells contained undetectable amounts of transferase mRNA. The mRNA levels were not induced in human cells by treatments that induce other DNA damage-inducible genes. These results demonstrate that in human cells the transferase gene is constitutively expressed, that its expression is related to activity levels, and that in Mer- tumor cells the expression of the transferase gene is probably blocked at the level of mRNA production.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253230

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients.

Authors:  Carmen Balańa; Cristina Carrato; José Luis Ramírez; Andrés Felipe Cardona; Mireia Berdiel; José Javier Sánchez; Miquel Tarón; Cristina Hostalot; Eva Musulen; Aurelio Ariza; Rafael Rosell
Journal:  Clin Transl Oncol       Date:  2011-09       Impact factor: 3.405

2.  Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O⁶-methylguanine-DNA methyltransferase and mismatch repair proteins.

Authors:  Christiane Querfeld; Steven T Rosen; Joan Guitart; Alfred Rademaker; David S Pezen; M Eileen Dolan; Joseph Baron; Daniel B Yarosh; Francine Foss; Timothy M Kuzel
Journal:  Clin Cancer Res       Date:  2011-07-11       Impact factor: 12.531

3.  Promoter hypermethylation of DNA repair gene MGMT in laryngeal squamous cell carcinoma.

Authors:  Song Zhang; Changkai Guo; Weijia Kong; Zheng Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas.

Authors:  J L Blanc; M Wager; J Guilhot; S Kusy; B Bataille; T Chantereau; F Lapierre; C J Larsen; L Karayan-Tapon
Journal:  J Neurooncol       Date:  2004-07       Impact factor: 4.130

5.  Intercellular heterogeneity of expression of the MGMT DNA repair gene in pediatric medulloblastoma.

Authors:  Brian R Rood; Huizhen Zhang; Philip H Cogen
Journal:  Neuro Oncol       Date:  2004-07       Impact factor: 12.300

6.  Characterization of the promoter region of the human O6-methylguanine-DNA methyltransferase gene.

Authors:  L C Harris; P M Potter; K Tano; S Shiota; S Mitra; T P Brent
Journal:  Nucleic Acids Res       Date:  1991-11-25       Impact factor: 16.971

7.  Interrelationship between O6-alkylguanine-DNA alkyltransferase activity and susceptibility to chloroethylnitrosoureas in several glioma cell lines.

Authors:  T Hotta; Y Saito; T Mikami; K Kurisu; K Kiya; T Uozumi; G Isowa; K Ishizaki; M Ikenaga
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

8.  Inducibility of the DNA repair gene encoding O6-methylguanine-DNA methyltransferase in mammalian cells by DNA-damaging treatments.

Authors:  G Fritz; K Tano; S Mitra; B Kaina
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

9.  Identification of a 59 bp enhancer located at the first exon/intron boundary of the human O6-methylguanine DNA methyltransferase gene.

Authors:  L C Harris; J S Remack; T P Brent
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

10.  Silencing of MGMT expression by promoter hypermethylation in the metaplasia-dysplasia-carcinoma sequence of Barrett's esophagus.

Authors:  Doerthe Kuester; Wa'el El-Rifai; DunFa Peng; Petra Ruemmele; Ivonne Kroeckel; Brigitte Peters; Christopher A Moskaluk; Manfred Stolte; Klaus Mönkemüller; Frank Meyer; Hans-Ulrich Schulz; Arndt Hartmann; Albert Roessner; Regine Schneider-Stock
Journal:  Cancer Lett       Date:  2008-11-21       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.